Experimental study demonstrates the synthesis and photophysical properties of cyclometalated rhodium and iridium complexes, indicating their utility as catalytic reaction intermediates.
Cyclometalation reactions proceeding by a concerted metalation-deprotonation mechanism are recognized as efficient routes toward new organometallic compounds. Using this approach, we reacted 6-(4-tolyl)phenanthridine (1) and 6-(4-(trifluoromethyl)phenyl)phenanthridine (2) with [(η5-C5Me5)MCl2]2 (M = Rh and Ir) in the presence of sodium acetate and obtained the respective cyclometalated products [(η5-C5Me5)MCl(1–H)] and [(η5-C5Me5)MCl(2–H)] in varying yields (20–80%). An unexpected product of 2-fold C–H bond activation [Rh(OAc)(1–H)2] (3) was also isolated. The compounds were characterized by NMR spectroscopy and mass spectrometry, and the structures of the representative complexes were determined by single-crystal X-ray diffraction analysis. In addition, the photophysical properties of the cyclometalated compounds were studied using UV–vis and luminescence spectroscopy, and the data were rationalized by DFT calculations. The reaction of [(η5-C5Me5)RhCl(1–H)] with tolane in the presence of a Cu(II) salt as an oxidant afforded 9-methyl-6,7-diphenylisoquinolino[2,1-f]phenanthridin-5-ium tetrafluoroborate, an annulated product, which suggested that the cyclometalated complexes are plausible intermediates of such annulation reactions.
No takes yet. Share an insight, caveat, or question.
Harmach et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: